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Abstract
Background: Increased systemic cytokines and elevated brain levels of monoamines, and hydroxyl radical
productions are thought to aggravate the conditions of cerebral ischemia and neuronal damage during heat
stroke. Dexamethasone (DXM) is a known immunosuppressive drug used in controlling inflammation, and
hydroxyethyl starch (HES) is used as a volume-expanding drug in cerebral ischemia and/or cerebral injury. Acute
treatment with a combined therapeutic approach has been repeatedly advocated in cerebral ischemia
experiments. The aim of this study is to investigate whether the combined agent (HES and DXM) has beneficial
efficacy to improve the survival time (ST) and heat stroke-induced cerebral ischemia and neuronal damage in
experimental heat stroke.
Methods: Urethane-anesthetized rats underwent instrumentation for the measurement of colonic temperature,
mean arterial pressure (MAP), local striatal cerebral blood flow (CBF), heart rate, and neuronal damage score. The
rats were exposed to an ambient temperature (43 degrees centigrade) to induce heat stroke. Concentrations of the
ischemic and damage markers, dopamine, serotonin, and hydroxyl radical productions in corpus striatum, and the
serum levels of interleukin-1 beta, tumor necrosis factor-alpha and malondialdehyde (MDA) were observed during
heat stroke.
Results: After heat stroke, the rats displayed circulatory shock (arterial hypotension), decreased CBF, increased the
serum levels of cytokines and MDA, increased cerebral striatal monoamines and hydroxyl radical productions
release, and severe cerebral ischemia and neuronal damage compared with those of normothermic control rats.
However, immediate treatment with the combined agent at the onset of heat stroke confers significant protection
against heat stroke-induced circulatory shock, systemic inflammation; cerebral ischemia, cerebral monoamines and
hydroxyl radical production overload, and improves neuronal damage and the ST in rats.
Conclusions: Our results suggest that the combination of a colloid substance with a volume-expanding effect and
an anti-inflammatory agent may provide a better resuscitation solution for victims with heat stroke.
Background
Unless immediately recognized and treated, heat stroke
is often lethal, and victims who do survive may sustain
permanent neurological damage [1]. The clinical diagno-
sis of heat stroke is demonstrated when hyperthermia is
accompanied with circulatory shock (arterial hypoten-
sion), intracranial hypertension, and cerebral ischemia
and injury [2,3]. Meanwhile, the heat stroke-induced
central nervous system dysfunction includes delirium,
convulsion, or coma [4]. Hence, prolonging survival
time in heat stroke victims may offer more sufficient
time for urgent treatment, thereby ameliorating the heat
stroke-induced damage. * Correspondence: ccliu@mail.chna.edu.tw
4Department and Institute of Cosmetic Science, Chia-Nan University of
Pharmacy and Science, Tainan 71710, Taiwan
Full list of author information is available at the end of the article
Yang et al. Experimental & Translational Stroke Medicine 2010, 2:19
http://www.etsmjournal.com/content/2/1/19
© 2010 Yang et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Several lines of evidence indicate that rodents share
with humans almost the same heat stroke syndromes,
such as arterial hypotension, activated inflammation,
and multiorgan dysfunction (in particular, cerebral
ischemia, injury, and dysfunction [5-7]. In the rodents
heat stroke model, significant decrements in both mean
arterial pressure (MAP) and cerebral blood flow (CBF),
but increments of cerebral monoamines levels, free radi-
cal productions and systemic cytokine levels are
obtained in urethane-anaesthetized rats after heat stroke
[8,9]. These pathophysiological changes are known to
aggravate the conditions of cerebral ischemia and neuro-
nal damage during heat stroke in rats [10]. Activated
inflammation is evidenced by overproduction of pro-
inflammatory cytokines (e.g., interleukin-1b (IL-1b)a n d
tumor necrosis factor-a (TNF-a)) in circulation of heat
stroke rats [11,12]. High levels of cytokines and radicals
in the peripheral blood stream, as well as excessive
accumulation of glutamate, hydroxyl radicals, dopamine
(DA) and serotonin (5-HT) in the central brain, corre-
late with the severity of circulatory shock, cerebral
ischemia and neuronal damage during heat stroke in
rats [6,9,13,14].
Various clinical and experimental investigations have
shown that single doses of dexamethasone (DXM; exo-
genous glucocorticoids) or hydroxyethyl starch (HES)
are extensively used in the treatment of cerebral ische-
mia and/or cerebral injury [15-17]. In the studies of
heat stroke, systemic treatment with DXM attenuated
serum IL-1b levels and cerebral ischemia damage, and
improved survival in heat stroke [18]. Additionally, the
prolongation of survival in rats with HES therapy was
found to be associated with augmentation of both arter-
ial blood pressure and CBF as well as reduction of cere-
bral ischemia, hypoxia, and neuronal damage during
heat stroke [19]. Although, many therapeutic agents
show potential promise in many animal models, the
results of most single-agent clinical trials are sobering.
Consequently, various authors advocate studies to esti-
mate the efficacy of combined therapeutic approaches
[20,21]. Furthermore, there is less attention to evaluate
immediate effects of both DXM and HES (the combined
agent) on heat stroke-induced pathophysiological
changes, let alone their neuroprotective underlying
influences, especially in the aspects of striatal monoa-
mines and hydroxyl radical production release. Based on
these concepts, we propose whether application of the
combined agent immediate treatment has efficacy to
elongate the survival time, and improve the heat stroke-
induced circulatory shock, cerebral ischemia, and neuro-
nal damage in rats. Furthermore, we also attempt to
ascertain whether the neuroprotective effects of the
combined agent treatment are associated with inhibition
of cerebral release of glutamate, DA, 5-HT, hydroxyl
radicals, and the serum IL-1b,T N F - a and malondialde-
hyde (MDA) levels during heat stroke.
Methods
Experimental animals
Male Spraque-Dawley rats weighing between 300 and 350
g were obtained from the National Science Council of
Republic of China (Taiwan). Between experiments the ani-
mals were housed individually at an ambient temperature
of 24 ± 1°C with a 12-h light-dark cycle, with the lights
being switched on at 0600 h. Animal chow and water were
allowed ad libitum. All protocol were approved by the
Animal Ethics Committee of the Chia-Nan University of
Pharmacy and Science, Tainan, Taiwan (approbated no.
CN-IACUC-94007) in accordance with the Guide for the
Care and Use of Laboratory Animals of the National Insti-
tutes of Health and the guidelines of the Animal Welfare
Act. Adequate anesthesia was maintained to abolish the
corneal reflex and pain reflexes by tail-pinching through-
out all experiments (approximately 8 hr) by a single intra-
peritoneal dose of urethane (1.4 g.kg
-1 b.w., i.p.). At the
end of the experiments, control rats (and any rats that had
survived heat stroke) were killed with an overdose of
urethane. One hundred thirty-eight rats were used in this
study. Fifty-three rats of 138 were used for examining in
T a b l e1 ,F i g u r e1a n d2( t h r ee premature deaths during
heat stroke induction and two premature deaths during
animal surgery). Forty-three rats of 138 were used for
examining in Table 2 (three premature deaths during heat
stroke induction). Forty-two rats of 138 were used for
examining in Figure 3 and 4 (two premature deaths during
heat stroke induction). No premature deaths during
anesthesia.
Animal surgery and physiological parameter monitoring
Under urethane anesthesia, the right femoral artery of the
rats was cannulated with polyethylene tubing (PE50) for
physiological monitoring, the right femoral vein was also
cannulated for blood sampling and drug administration.
The animals were then positioned in a stereotaxic appa-
ratus (Kopf model 1460) for measurement of CBF and
microdialysis experiment. Physiological monitoring
included colon temperature (TCO), MAP, heart rate
(HR) and CBF values in the cerebral corpus striatum.
Experimental groups
Rats were randomly assigned to one of six major groups.
One group of rats (n = 8) with heat stroke received nor-
mal saline (NS) treatment (1 or 11 ml/kg body wt, 0.9%
NaCl solution, i.v.) at the onset of heat stroke. Heat
stroke was induced by exposing the animals to an ambi-
ent temperature of 42°C (with a relative humidity of 60%
in a temperature-controlled chamber). The moment in
which MAP and local CBF began to sharply decrease
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of heat stroke, as shown in Figure 1. The interval between
the start of heat exposure and onset of heat stroke were
taken as values of latency. The interval between the
initiation of heat stroke onset and animal death were
taken as values of survival time. Another group of rats
(n = 8) with heat stroke respectively received DXM 4
m g / k gi . v . ,H E S( 1 0 % ,1 1m l / k gi . v . ,F r e s e n i u sA G ,B a d
Homburg, Germany), or the combined agent [DXM
(4 mg/ml/kg) together with HES (10%, 11 ml/kg)] i.v. at
the onset of heat stroke. The other group of rats (n = 8)
were normothermic control rats which were exposed to
an ambient temperature of 24°C for at least 90 min to
reach thermal equilibrium. Their physiological para-
meters were continuously recorded for up to 480 min (at
the end of experiment). Their colon temperatures were
maintained at about 36°C using the electric thermal mat
before the start of experiments. The rats of these groups
were continually monitored from physiological para-
meters (such as TCO, MAP, HR, and CBF) and ST during
heat stroke. According to the values of ST, rats treated
with the combined agent displayed the best beneficial
effect on prolongation of ST in Table 1. Consequently,
investigation of the heat stroke-induced circulatory
shock, cerebrovascular dysfunction, cerebral ischemia
and neuronal damage would be emphasized by the influ-
ence of the combined agent administration.
Measurements of Cellular Ischemia and Injury Markers
After cannulation of vessels, the animal’sh e a dw a s
mounted on a stereotaxic apparatus (Davis Kopf Instru-
ments) with the nose bar positioned 3.3 mm below the
horizontal line. Following a midline incision, the skull
was exposed and a burr hole was made in the skull for
the insertion of a dialysis probe (4 mm in length, CMA/
12, Carnegie Medicine, Stockholm, Sweden). The micro-
dialysis probe was stereotaxically implanted into the cor-
pus striatum according to the atlas and coordinates of
Paxinos and the coordinates of Paxinos and Watson
(1982) [22]. As the methods described previously
[19,23], an equilibrium period of 2 hours without sam-
pling was allowed after probe implantation. The dialysis
probe was perfused with Ringer’s solution (147 mM Na
+,2 . 2m MC a
2+,4m MK
+,p H7 . 0 )a t2μl/min using a
CMA/100 microinfusion pump. Dialysates were
collected every 20 min in a CMA140 fraction collector.
Aliquots of dialysates (5 μl) were injected onto a
CMA600 Microdialysis Analyzer (Carnegie Medicine)
for measurement of lactate, glycerol, pyruvate and gluta-
mate. Four analytes can be analyzed per sample and the
result is displayed graphically within minutes. The ther-
mal experiments were started after showing stabilization
in four consecutive samples.
The lactate/pyruvate ratio is a well-known marker of cell
ischemia, that is, an inadequate supply of oxygen and glu-
cose. Glycerol is a marker of how severely cells are affected
by the ongoing pathology. Glutamate is released from neu-
rons during ischemia and initiates a pathological influx of
calcium leading to cell damage. It is an indirect marker of
cell damage in the brain, as described previously [19,23].
Measurements of Extracellular DA and 5-HT release
Dialysates samples were collected at 20 min intervals
and assayed by an HPLC system. Extracellular monoa-
mine concentrations were assayed by HPLC combined
with an electrochemical detection system. The HPLC
system comprised a Beckman 126 pump (BeckmanIn-
stru-ments) and a CMA-200 microautosampler (CMA/
Microdialysis, Stockholm, Sweden), and a microbore
reversed-phase column was filled with Inertsil ODS-2
(GSK-C18, 5-mmOD, 150 × 1.0-mmID). The perfor-
mance of each microdialysis probe was calibrated by
dialysis of a known amount of the standard mixture,
and recovery of all analyses was then determined. Brain
concentrations of DA and 5-HT were calculated by
determining each peak height ratio relative to the
Table 1 Effects of heat exposure (HE; Ta = 42°C) on both latency for the onset of heat stroke and survival time in rats
treated with normal saline (NS), in rats treated with hydroxyethyl starch (HES), in rats treated with dexamethasone
(DXM), and in rats treated with HES +DXM
Treatment Latency (mins) Survival time (mins)
1. Rats treated with NS and kept at 24°C > 480
†, ‡ > 480
†, ‡,#
2. Rats treated with NS (1 ml/kg, i.v.) and kept at 42°C 82 ± 3* 23 ± 2*
,†, ‡
3. Rats treated with NS (11 ml/kg, i.v.) and kept at 42°C 79 ± 4* 34 ± 6*
, ‡
4. Rats treated with HES (10%, 11 ml/kg, i.v.) and kept at 42°C 81 ± 3* 177 ± 15*
,†,#
5. Rats treated with DXM (4 mg/kg, i.v.) and kept at 42°C 80 ± 3* 28 ± 7*
, ‡
6. Rats treated with DXM (4 mg/kg, i.v.)+HES (10%, 11 ml/kg, i.v.) and kept at 42°C 79 ± 4* 262 ± 17*
, †, ‡,#
NS or drugs were administered immediately after the onset of heat stroke.
Values are the means ± SEM of 8 rats per group. Groups 2-6 exposed to 42°C had heat exposure withdrawn at the onset of heat stroke.*P < 0.05, compared with
the corresponding control values (rats kept at 24°C; treatment 1). (one-way ANOVA, followed by Duncan’s test).
†P < 0.05, compared with the corresponding
control values (rats treated with NS (11 ml/kg) and kept at 42°C; treatment 3). (one-way ANOVA, followed by Duncan’s test).
‡P < 0.05, compared with the
corresponding control values (rats treated with HES (11 ml/kg) and kept at 42°C; treatment 4). (one-way ANOVA, followed by Duncan’s test).
#P < 0.05, compared
with the corresponding control values (rats treated with DXM (4 mg/kg) and kept at 42°C; treatment 5). (one-way ANOVA, followed by Duncan’s test).
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Figure 1 Physiological parameters, and cellular ischemia and injury markers. Effects of heat exposure (ambient temperature; Ta = 42°C for
80 min) on colonic temperature (Tco), mean arterial pressure (MAP), heart rate (HR), cerebral blood flow (CBF) and the extracellular
concentrations of glutamate, glycerol, and lactate/pyruvate ratio of the corpus striatum in normothermic control rats (open circles), 0.9% NaCl
solution (11 ml/kg)-treated (filled circles), DXM (4 mg/kg)-treated (open squares), HES (10%, 11 ml/kg)-treated (filled squares), or the combined
agent (DXM+HES)-treated rats (open triangles). The dotted line indicates time of heat stroke onset and drug injection. *P< 0.05, compared with
normothermic control rats.
†P< 0.05, compared with saline-treated rats (Ta = 42°C for 80 min).
#P< 0.05, compared with HES-treated rats (Ta =
42°C for 80 min) (ANOVA followed by Duncan’s test).
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Figure 2 Extracellular levels of dopamine, serotonin, and total production of DHBA. Effects of heat exposure (ambient temperature; Ta =
42°C for 80 min) on extracellular levels of dopamine, serotonin, and total production of dihydroxybenzoic acid (DHBA) of the cerebral corpus
striatum in normothermic control rats (open circles), 0.9% NaCl solution (11 ml/kg)-treated (filled circles), DXM (4 mg/kg)-treated (open squares),
HES (10%, 11 ml/kg)-treated (filled squares), or the combined agent (DXM+HES)-treated rats (open triangles). The dotted line indicates time of
heat stroke onset and drug injection. *P< 0.05, compared with normothermic control rats.
†P< 0.05, compared with saline-treated rats (Ta = 42°C
for 80 min).
#P< 0.05, compared with HES-treated rats (Ta = 42°C for 80 min) (ANOVA followed by Duncan’s test).
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Page 5 of 12internal standard and were also corrected by each probe
performance. The internal standard 3-methoxy-tyramine
and standard mixtures were prepared fresh daily. The
mobile phase was prepared by adding 60 ml of acetoni-
trile, 0.42 g of SDS (2.2 mM), 200 g of sodium citrate
(30 mM), 10 mg of EDTA (0.027 mM), and 1 ml of
diethylamine in double-distilled water.
Hydroxyl Radical Production Monitoring
The concentrations of hydroxyl radicals were measured
by a modified procedure based on the hydroxylation of
sodium salicylate by hydroxyl radicals, leading to pro-
duction of 2,3-dihydroxybenzoic acid (2,3-DHBA) and
2,5-DHBA. These two compounds were then measured
in dialysates by HPLC with electrochemical detection. A
Ringer’s solution (0.860 g of NaCl, 0.030 g of KCl and
0.033 g of CaCl2 per 100 ml) containing 2 mmol/l
sodium salicylate was perfused through the microdialysis
probe at a constant flow rate (1.2 μl/min) A reverse-
phase C18 column [phase II; particle size, 3 μm; 100 ×
3.2 mm (length×internal) diameter]; BioAnalytic Sys-
tems, West Lafayette, IN, U.S.A.] was used, and the
Table 2 Effects of heat exposure (42°C for 80 min) plus 25 min room temperature (24°C) exposure on the neuronal
damage score values of corpus striatum from normal saline-treated, dexamethasone(DXM), HES or the combined
agent (DXM+HES)-treated rats
a
Treatment Score of neuronal damage (0-3)
striatum
1. Normal saline (1 ml/kg, i.v.)-treated rats at 24°C 0 (0, 0.75)
2. Normal saline (1 ml/kg, i.v.)-treated rats at 42°C 2 (2, 2.25)
b
3. DXM (4 mg/kg, i.v.)-treated rats at 42°C 2 (2, 2)
b
4. HES (10%, 11 ml/kg, i.v.)-treated rats at 42°C 1 (0.25, 1)
c
5. DXM (4 mg/kg, i.v.)+HES (10%, 11 ml/kg, i.v.)-treated rats at 42°C 1 (0, 1)
c
aValues are means ± S.E. of 8 rats per group followed by median with Q1and Q3 in parenthesis. For determination of neuronal damage score animals were killed
after 80 mins heat exposure plus 25 mins room temperature exposure. The data were evaluated by a Wilcoxon signed rank test followed by Mann-Whitney test.
bP < 0.05, significance of difference from corresponding values (treatment 1, control rats).
cP < 0.05 significance of difference from corresponding values (treatment 2).
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Figure 3 Serum levels of MDA. Effects of heat exposure (42°C) on serum levels of malondialdehyde (MDA) in normothermic control rats (white
bar), 0.9% NaCl solution (11 ml/kg)-treated (black bar), DXM (4 mg/kg)-treated (diagonal bar), HES (10%, 11 ml/kg)-treated (cross bar) or the
combined agent (DXM+HES)-treated rats (gray bar). *P< 0.05, compared with normothermic control rats.
†P< 0.05, compared with saline-treated
rats (Ta = 42 for 80 min).
#P< 0.05, compared with HES-treated rats (Ta = 42°C for 80 min) (ANOVA followed by Duncan’s test). The blood
samples were acquired after 100 min the initiation heat exposure in heat stroke rats or the equivalent time in normothermic controls.
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Page 6 of 12mobile phase consisted of a mixture of 75 mmol/l
monochloroacetic acid, 0.7 mmol/l disodium EDTA, 1.5
mmol/l sodium 1-octanesulphonate and 45 ml/l acetoni-
trile (pH 3.0). The retention times of 2,3-DHBA and
2,5-DHBA were 9.07 and 5.44 min respectively.
Measurement of Serum MDA Levels
0.25 mL of serum was added to 25 μL of 0.2% BHT and
12.5 μL of 10 N NaOH (to adjust to pH~13) and incu-
bated at 60°C for 30 min in a shaking water bath. To
this was added 1.5 mL of 0.44 mol/L (or 7.2%) TCA
containing 1% KI, and the mixture was placed in ice for
10 min and centrifuged (1,000g,1 0m i n ) .T o1m Lo f
the supernatant was added 0.5 mL of 0.6% TBA, and
the mixture was heated at 95°C for 30 min. After cool-
ing the mixture was extracted with 1.5 mL of n-butanol,
and 20 μL of the butanol layer was injected to a C-18
(4.6 × 150 mm) column fitted with a guard and eluted
at 1 mL/min by using 65% (v/v) 50 mM KH2PO4-KOH
and 35% (v/v) methanol with spectrophotometric (532
nm) detector.
Measurement of Serum IL-1b and TNF-a Levels
The blood samples were acquired 100 min after the
initiation of heat exposure (or 20 min after the onset of
heat stroke) in heat stroke rats or the equivalent time in
normothermic controls. 5 ml of blood was withdrawn
from the femoral vein of each rat for measurement of
serum IL-1b or TNF-a. Blood samples were allowed to
clot for 2 hours at room temperature or overnight at 2-
8°C before centrifuging for 20 minutes at approximately
2000 ×g. Serum was quickly removed from these plasma
samples and assayed for IL-1b or TNF-a immediately.
The DuoSet Enzyme-linked Immunosorbent Assay
(ELISA) Development System rat IL-1b or TNF-a kit
(R&D Systems, Minneapolis, MN, USA) was used for
measuring the levels of active rat IL-1b or TNF-a pre-
sent in serum. This assay employs the quantitative
colorimetric sandwich ELISA technique.
Neuronal Damage Score
At the end of each experiment, the brain was removed,
fixed in 10% neutral buffered formalin and embedded in
paraffin blocks. Serial (10 μm) sections through the
striatum were stained with hemotoxylin and eosin for
microscopic evaluation. The extent of striatal neuronal
damage was scored on a scale of 0-3, modified from the
grading system of Pulsinelli et al. (1982) [24], in which 0
is normal, 1 means that ~30% of the neurons are
damaged, 2 means that ~60% of that neurons are
damaged, and 3 means that 100% of that neurons are
damaged. Each hemisphere was evaluated independently
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Figure 4 Serum levels of IL-1b and TNF-a. Effects of heat exposure (42°C) on serum levels of interleukin-1b (IL-1b) and tumor necrosis factor-
a (TNF-a) in normothermic control rats (white bar), 0.9% NaCl solution (11 ml/kg)-treated (black bar), DXM (4 mg/kg)-treated (diagonal bar), HES
(10%, 11 ml/kg)-treated (cross bar) or the combined agent (DXM+HES)-treated rats (gray bar). *P< 0.05, compared with normothermic control
rats.
+P< 0.05, compared with saline-treated rats (Ta = 42°C for 80 min).
#P< 0.05, compared with HES-treated rats (Ta = 42°C for 80 min).
(ANOVA followed by Duncan’s test). The blood samples were acquired after 100 min the initiation heat exposure in heat stroke rats or the
equivalent time in normothermic controls.
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Page 7 of 12without the examiner knowing the experimental condi-
tions. When examined for neuronal damage in gray
matter, only areas other than those invaded by probes
were assessed.
Statistical analysis
Data are presented as the mean ± SEM. Repeated-mea-
sures analysis of variance was used for factorial experi-
ments, whereas Duncan’s multiple-range test was used
for post hoc multiple comparisons among means. For
scoring neuronal damage, the Wilcoxon signed rank test
was used when only two groups were compared. The
Wilcoxon tests which convert the scores or values of a
variable to ranks, require calculation of a sum of the
ranks and provide critical values for the sum necessary
to test the null hypothesis at a given significant level.
T h ed a t aw e r eg i v e nb y“median”, and first and third
quartile. A P value less than 0.05 was considered as sta-
tistical significance.
Results
The combined agent (DXM+HES) improves survival time
in heat stroke
Table 1 summarizes the effects of heat exposure (42°C
Ta for 80 min) on survival time in rat heat stroke. In
anesthetized rats treated with intravenous (i.v.) doses of
normal saline (NS) or drugs immediately after the onset
of heat stroke, although showing no change in latency,
displayed increases in survival time in some groups. For
example, rats treated with an i.v. dose of 1 ml/kg or 11
ml/kg of NS had survival time values of 23 ± 2 min or
34 ± 6 min, respectively. Rats treated with HES solution
at an i.v. dose of 11 ml/kg immediately after the onset
of heat stroke had a survival time value of 177 ± 15
min. This increase in survival would indicate that the
HES, but not the NS groups, are adequately resuscitated.
Additionally, although immediate treatment with DXM
(4 mg/kg) alone had no apparent beneficial effect, the
combined agent (combined administration of DXM
(4 mg/kg) plus HES (11 mg/kg)) immediately after the
onset of heat stroke did prolong the survival time as
compared with the controls (as shown in Table 1).
The combined agent (DXM+HES) attenuates hypotension,
cerebrovascular dysfunction and neuronal damage during
heat stroke
The effects of heat exposure (42°C for 80 min) on sev-
eral physiological parameters in NS-, DXM-, HES- and
the combined agent-treated rats are shown in Figure 1.
In NS-treated (11 ml/kg) and DXM (4 mg/kg)-treated
groups, the values of MAP and CBF were significantly
decreased at 10 or 20 min after the onset of heat stroke
(or 90 or 100 min after the start of heat stress) com-
pared with those of normothermic controls. On the
other hand, the values of extracellular concentrations of
glutamate, glycerol and lactate/pyruvate ratio in the cor-
pus striatum were significantly greater than those of the
normothermic controls. In HES (11 ml/kg)-treated
group, rats displayed greater MAP and CBF, but lower
striatal levels of glutamate, glycerol, and lactate/pyruvate
ratio after onset of heat stroke than those of the NS-or
DXM- treated rats. However, heat stroke-induced arter-
ial hypotension, cerebral ischemia and increased levels
of glutamate, glycerol, and lactate/pyruvate ratio in the
extracellular levels of striatum were all significantly
diminished by treatment with the combined agent
immediately at the onset of heat stroke or 80 min after
start of heat stress.
In separate experiments, 25 min after the onset of
heat stroke, rats were sacrificed for determination of
neuronal damage score in the corpus striatum. The data
a r es u m m a r i z e di nT a b l e2 .A f t e rt h eo n s e to fh e a t
stroke, rats treated with NS (11 ml/kg) displayed higher
values of striatal neuronal damage [2 (2, 2.25)] com-
pared with those of normothermic controls [0 (0, 0.75)]
( a ss h o w ni nT a b l e2a n dF i g u r e5 B ) .V a l u e so fs t r i a t a l
neuronal damage score in the DXM-treated rats and in
the HES-treated rats were respectively [2 (2, 2)] and
[1 (0.25, 1)]. However, with the combined agent [DXM
(4 mg/kg)+HES (11 ml/kg)] acute treatment, neuropro-
tection ensured [1 (0, 1)]. Figure 5 shows that heat
stroke-induced cell shrinkage, pyknosis of nucleus, and
disappearance of nucleolus in the corpus striatum were
attenuated by the combined agent (Figure 5C).
The combined agent (DXM+HES) reduces cerebral striatal
levels of dopamine, serotonin and DHBA during heat
stroke
As shown in Figure 2, twenty minutes after the termina-
tion of heat stress in the NS-treated group or DXM-
treated group, all the dopamine, serotonin, and DHBA
(dihydroxybenzoic acid, indirectly stood for production
of hydroxyl radicals) values in cerebral striatum were
significantly greater than those of the normothermic
controls (P < 0.05). Immediate treatment with the com-
bined agent at the onset of heat stroke (80 min after the
start of heat stress) significantly attenuated the heat
stress-induced increases levels of dopamine, serotonin,
and production of hydroxyl radicals in the corpus
striatum.
The combined agent (DXM+HES) reduces the levels of
MDA, IL-1b and TNF-a in peripheral blood stream during
heat stroke
The serum IL-1b and TNF-a, and MDA levels for nor-
mothermic controls, NS-, DXM-, HES-treated heat
stroke rats, and the combined agent-treated heat stroke
rats are summarized in Figure 3 and 4. It can be seen
Yang et al. Experimental & Translational Stroke Medicine 2010, 2:19
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MDA levels in NS-treated heat stroke rats were all
significantly higher at 20 min after the onset of heat
stroke than those in the normothermic controls. The
immediate treatment with HES alone and the combined
agent at the onset of heat stroke attenuated the heat
stroke-induced increased serum lipid peroxidation, as
well as attenuating it increased the serum levels of IL-1b
and TNF-a. However, these serum levels were more sig-
nificantly diminished by treatment with the combined
agent immediately at the onset of heat stroke (as shown
in Figure 3 and 4).
Discussion
It has been reported that pretreatment with DXM
(4 mg/kg) single dose, but not immediate treatment
with DXM, before heat stress could increase the ST in
rats by attenuating serum levels of interleukins [18];
however, there are fewer studies showing the immediate
treatment with the combined agent at the onset of heat
stroke. It will be more meaningful the combined treat-
ment shows neuroprotection after heat stroke attacks.
Although the previous results [19] have shown an insig-
nificant therapeutic effect of DXM (4 mg/kg) adminis-
tered immediately after the onset of heat stroke alone,
the combination of DXM and HES provides a better
therapeutic effect for rats with heat stroke in the present
study. Additionally, the volume-expanding effect of the
HES would be thought to improve survival during heat
stroke in resuscitation. The HES would be 1.5-2 times
the volume administered by 1-2 hour after it is given. In
fact, in our previous study, intravenous infusion of 2-11
ml/kg of HES solution improved survival in a dose-
dependent manner during heat stroke, and suggesting
treatment with 11mg/kg of HES had better prolongation
in survival. Hence, the HES that acts to expand the cir-
culatory volume and a potent inflammatory agent (such
as DXM) might be combined to develop an improved
fluid therapy for attenuation or prevention of heat
stroke-induced damage. Although our previous results
indicated that the combination of HES and DXM did
provide a better survival effect for rats with heat stroke,
the hemodynamic, histological and biological changes by
the combined treatment immediately after the onset of
heat stroke were not observed in detail. In this study,
administration of the combined agent indeed appears
more effective to prolong the ST in rats with heat
stroke, by comparison to treatment of DXM or HES
alone (shown in table 1). Similarly, in agreement with
the present results, treatment of the combined agent
(DXM and HES) can also offer beneficial amelioration
from ischemic condition and therapeutic influence in
ischemic experiments [25,26]. There is evidence that
cerebral ischemia (due to arterial hypotension and
A 
B
C 
Figure 5 Histological examination of neuronal damage.T h e
photomicrographs of the cerebral corpus striatum in a
normothermic control rat treated with 0.9% NaCl solution (11 ml/
kg) (A), a heat stroke rat treated with 0.9% NaCl solution (11 ml/kg)
(B), or a heat stroke rat treated with the combined agent (DXM
+HES) (C) immediately after the initiation of heat stroke. The striatal
photomicrograph in a heat stroke rat treated with DXM (4 mg/kg) is
similar to (B), and in a heat stroke rat treated with HES (10%, 11 ml/
kg) is similar to (C) (data not shown). Twenty-five minutes after 80-
min heat exposure, the corpus striatum of the rat treated with 0.9%
NaCl solution showed cell shrinkage, pyknosis of the nucleus, and
disappearance of nucleolus. After acute treatment with the
combined agent, neuronal damage was reduced, as shown in C.
The rats were sacrificed at 25 min after the termination of heat
exposure or the equivalent time for the normothermic controls.
Scale bar, 50 μm.
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causes to induce further damage after heat stroke onset
[13,18,19]. After heat stroke induction, the CBF instantly
drops from highest peak, and it is concomitant with sig-
nificant increments of cerebral ischemia and injury
indexes, as shown in figure 1. The lactate/pyruvate ratio
is a well known marker of cellular ischemia, whereas
glycerol is a marker of how severely cells are affected by
ongoing pathology [27]. Excessive accumulation of glu-
tamate has been shown in ischemic brain tissue [27].
Indeed, both present and previous results [19,23,27]
have demonstrated that extracellular levels of glutamate,
glycerol and lactate/pyruvate in ischemic brain are
greater in heat stroke rats compared with those of nor-
mothermic controls. Meanwhile, evidences of histo-
pathological morphology and neuronal damage scores
also reveal severe neuronal damage (shown in figure 5,
table 2) in heat stroke rats. However, as shown in the
present results, all these heat stroke-induced cerebral
ischemia and injury can be alleviated by acute treatment
with the combined agent.
There were many evidences [8,14,28] that the
increased DA, 5-HT and glutamate in the brain during
the rat heat stroke were mediated in the development of
neuronal damage. Cerebral DA, 5-HT or/and glutamate
overload resulting from arterial hypotension and intra-
cranial hypertension might be responsible for occur-
rence of central nervous system syndromes associated
with heat stroke [14,28]. Systemic administration of
dopaminergic or serotoninergic nerve depletors or
receptor antagonists, or glutamate receptor antagonists
cloud protect against ischemic neuronal injury in experi-
mental heat stroke [14,28,29]. In addition, recent studies
showed that the excessive accumulation of cytotoxic
free radicals in the brain and oxidative stress occurred
during heat stroke [9,10,30]. Evidence had accumulated
to suggest that heat stroke-induced cerebral ischemia
and neuronal damage might be associated with an
increased production of free radicals, specifically hydro-
xyl radicals [9,10]. Pretreatment with hydroxyl radical
scavengers, such as a-tocopherol, prevented production
of hydroxyl radicals, reduced lipid peroxidation and
ischemic neuronal damage in the brain of rats exposed
to heat stroke and prolonged subsequent survival [31].
In brief, as demonstrated by Chang et al, after the onset
of heat stroke, cessation or reduction of blood flow to
the brain induced neuronal damage. This neurotoxic
cascade involved overproduction of glutamate, DA, and
5-HT as well as oxidative stress in the brain [6]. Like-
wise, in the present study, heat stroke also produces
similar increases in cerebral striatal DA, 5-HT, gluta-
mate and hydroxyl radical production in heat stroke
rats. Additionally, the heat stroke rats also displayed
increased levels of lipid peroxidation in the peripheral
blood stream. Indeed, according to our present findings,
the heat stroke-induced high levels of DA, 5-HT, gluta-
mate, and hydroxyl radicals in rats’ corpus striatum, and
the elevated plasma MDA levels can be prevented by
acute treatment with the combined agent. This probably
implies that the immediate administration of the com-
bined agent during heat stroke may be mediated with
the decrements of cerebral monoamines and oxidative
stress to prolong the ST and improve the cerebral neu-
ronal damage in rats.
The serum concentrations of inflammatory cytokines
(such as IL-1b and TNF-a) are elevated in humans and
animals with heat stroke [12,18,23,32]. The levels of
both TNF-a and IL-1 receptors correlate well with
severity of heat stroke [32,33]. The previous studies had
also shown that heat stroke induced systemic and cere-
bral striatal productions of IL-1b and TNF-a in both
rats and rabbits [9,31,34,35]. Indeed, as it is shown in
the present results, an increase of serum IL-1b and
TNF-a levels is observed in heat stroke rats. The
increase in the levels of these inflammatory cytokines is
associated with arterial hypotension, cerebral ischemia
and neuronal damage. Administration of IL-1 receptor
antagonists could prevent arterial hypotension and cere-
bral ischemic damage, and improve survival in heat
stroke. Furthermore, the present results show that treat-
ment with the combined agent significantly attenuates
the heat stroke-induced overproduction of IL-1b and
TNF-a in the serum. Meanwhile, both arterial hypoten-
sion and cerebral ischemic damage are attenuated and
survival of heat stroke rats is ameliorated following
acute treatment with the combined agent. The immedi-
ate administration of this combined agent might exert
its protective effects by attenuating the increased plasma
level of IL-1b and TNF-a during heat stroke.
Our results indicated that following heat stroke, arter-
ial hypotension, decreased cerebral blood flow, increased
serum levels of IL-1b,T N F - a and MDA, and increased
striatal dopamine, serotonin and hydroxyl radicals and
increased of levels of glutamate, glycerol and lactate/pyr-
uvate ratio developed. Although HES administration
alone showed a pronounced effect, it was found that
treatment with the combined agent conferred a moder-
ate further beneficial effect to ameliorate these changes,
and improve neuronal damage and survival time. Var-
ious clinical and experimental investigations of stroke
and brain injury have shown that HES administration
might reduce brain edema and intracranial hypertension
[36-38]. It was also obtained that the values of MAP,
cerebral perfusion pressure (CPP), and cerebral levels of
local CBF were significantly lower during heat stroke
[6,27]. The maintenance of appropriate levels of CBF
m i g h tb eb r o u g h ta b o u tb yh igher CPP resulting from
lower intracranial pressure (ICP; possibly due to
Yang et al. Experimental & Translational Stroke Medicine 2010, 2:19
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tion) and higher MAP during development of heat
stroke [39]. This raises the possibility that HES might be
a beneficial treatment for heat stroke subjects with
intracranial hypertension as well as decreased cerebral
perfusion. As a result of present study, we see from
Figure 1, 2, 3 and 4, and Table 1 and 2 that acute treat-
ment with HES (11 ml/kg) alone at the onset of heat
stroke can alleviate the heat stroke-induced arterial
hypotension, cerebral monoamines and hydroxyl radical
production overload, systemic inflammation, and severe
cerebral ischemia and damage. However, treatment with
t h ec o m b i n e da g e n t( b o t hH E Sa n dD X M )h a sm o r e
effective therapy than treatment with HES alone to
maintain appropriate levels of MAP and CBF by attenu-
ating the heat stroke-induced abnormal physiological
and pathological changes, and results in prolongation in
survival (as shown in Figure 1, 2, 3 and 4, and Table 1).
Therefore, HES treatment showed partial effects on
those parameters after heat stroke induction. According
to our present results, it is reasonable to assume that
acute treatment with both HES and DXM has a better
effectiveness on reducing the heat stroke-induced
damage, and augmenting ST. It is not known whether
HES treatment exerts its benefit effect in heat stroke by
acting through attenuation of brain edema and intracra-
nial hypertension in present study. Of course, this needs
further investigation.
Conclusions
In the present study, the heat stroke-induced increases
in arterial hypotension, cerebral ischemia and neuronal
damage are associated with elevated levels of DA, 5-HT,
glutamate and hydroxyl radicals in rat brain, and
increased circulating IL-1b,T N F - a and MDA in the
peripheral blood stream. The immediate systemic treat-
ment with the combined agent (both DXM and HES),
in addition to attenuating the elevating levels of IL-1b,
TNF-a and MDA in blood stream, diminishes monoa-
mines, glutamate, and hydroxyl radical formation, and
ischemia injury in the brain, and improves ST in rats
with heat stroke. Our results suggest that the combina-
tion of a colloid substance with a volume-expanding
effect and an anti-inflammatory agent may provide a
better resuscitation solution for victims with heat stroke.
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